A. Loft

Complement C3d is not associated with axial spondyloarthritis and magnetic resonance imaging changes at the sacroiliac joint

I. Brandslund, B. Schiøttz-Christensen, A. Jurik, 2021, Scandinavian journal of rheumatology.

FRI0190 Clinical outcomes from a nationwide non-medical switch from originator to biosimilar etanercept in patients with inflammatory arthritis after 5 months follow-up. results from the danbio registry

B. Glintborg, M. Hetland, S. Chrysidis, 2017 .

Structural progression rate decreases over time on serial radiography and magnetic resonance imaging of sacroiliac joints and spine in a five-year follow-up study of patients with ankylosing spondylitis treated with tumour necrosis factor inhibitor

M. Østergaard, G. Thamsborg, R. Said-Nahal, 2018, Scandinavian journal of rheumatology.

The discriminative value of inflammatory back pain in patients with persistent low back pain

M. Østergaard, C. Manniche, K. Hørslev-Petersen, 2016, Scandinavian journal of rheumatology.

Diagnosing axial spondyloarthritis by multidiciplinary team conference at 3.5 years’ follow-up in a cohort of patients with disease features according to the ASAS criteria

A. Jurik, O. Hendricks, A. Loft, 2021, Scandinavian journal of rheumatology.

Disease activity-guided tapering of biologics in patients with inflammatory arthritis: a pragmatic, randomized, open-label, equivalence trial.

L. Dreyer, R. Christensen, R. Østgård, 2023, Scandinavian journal of rheumatology.

SAT0371 Hla-B27 Status Is Associated with tnfα Inhibitor Treatment Outcomes in Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis – Observational Cohort Study from The Nationwide Danbio Registry

M. Østergaard, J. K. Pedersen, L. Dreyer, 2016 .

Enthesitis in a European registry-based cohort of patients with psoriatic arthritis treated with tumour necrosis factor inhibitors: clinical burden, patient-reported outcomes, and treatment response

B. Glintborg, Ž. Rotar, H. Relas, 2024, Scandinavian journal of rheumatology.